eFolder Inc. – Trademark Portfolio
Entity Type: 03
eFolder Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include AXCIENT, CLOUDFINDER, and PROTECT EVERYTHING. The owner is based in Denver, CO.
Suite 3900
707 17th St.
Denver, CO 80202
Showing of trademarks Trademarks
Trademark Classifications
eFolder Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does eFolder Inc. have?
eFolder Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does eFolder Inc. file in?
eFolder Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 35 (Advertising & Business), Class 39 (Transportation & Storage). Class 42 covers scientific and technological services; industrial analysis and research services.
What are eFolder Inc.'s most well-known trademarks?
eFolder Inc.'s registered trademark portfolio includes well-known marks such as AXCIENT, CLOUDFINDER, and PROTECT EVERYTHING. These are among 3 currently registered trademarks in the portfolio.
What is eFolder Inc.'s trademark registration success rate?
eFolder Inc. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.